IRCT2016101727998N3已完成2 期
Compare the effect of extended-release toltoredine and solifenacin in the treatment of urinary frequency and nocturia in overactive bladder symptoms patients.
Vice Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Female
入选标准
- •Inclusion Criteria: Age more than 18 years; Urge incontinence; Mixed incontinence; urination in the day more than 8 times and urination in the night more than once; more than once a day with urge incontinence; Sense of urgency to urinate in 24 hours.
排除标准
- •Lack of consent to the participation; Contraindications received antimuscarinic drugs such as glaucoma.
研究者
相似试验
已完成
3 期
Diltiazem effects on overactive bladder syndromeOveractive bladder syndrome.other specified disorders of bladderIRCT201105096424N1Vice chancellor for research, kermanshah university of medical science80
已完成
3 期
The effect of Terazosin and Tolterodine in the treatment of double J stent-related urinary symptomsIRCT20160924029935N2Mashhad University of Medical Sciences80
已完成
3 期
A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic MonitoringUrinary Bladder, OveractiveNCT00646880Pfizer41
招募中
Unknown
Bioequivalence study of Tolterodine 2 mg tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N35Tabriz University of Medical Sciences24
已完成
4 期
Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in WomenUrinary IncontinenceNCT00143481Pfizer's Upjohn has merged with Mylan to form Viatris Inc.400